Search for: "Eli Lilly " Results 1181 - 1200 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2011, 9:59 pm by Patent Docs
USPTO (the Myriad case), the Court also handed down its opinion in Eli Lilly & Co. v. [read post]
9 Aug 2011, 8:38 pm by Eric Schweibenz
  In the Order, ALJ Rogers granted-in-part and denied-in-part Complainant Eli Lilly and Company’s (“Lilly”) motion for a presumption of infringement under 35 U.S.C. [read post]
9 Aug 2011, 8:24 pm by Eric Schweibenz
’s (collectively, “Teva”) motion to quash and/or limit the subpoenas duces tecum and ad testificandum issued upon application of Complainant Eli Lilly and Company (“Lilly”). [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
Violations of this act have led to multi-million dollar settlements with other pharmaceutical giants like Eli Lilly and Co. and Pfizer Inc. in the past. [read post]
5 Aug 2011, 9:55 pm by Patent Docs
Eli Lilly for compliance and patent challenges. [read post]
4 Aug 2011, 1:02 am by Editors
[via: Eli Lilly's law department goes into the classroom at InsideCounsel]Advertisement: * Find an In-House Counsel Job @ GoInhouse.com *Like this post? [read post]
3 Aug 2011, 3:31 am by Marie Louise
: Cour d’Appel Paris decision in Teva v Eli Lilly (Kluwer Patent Blog) US: CAFC confirms that isolated DNA may be patented: Association for Molecular Pathology v. [read post]
1 Aug 2011, 8:19 am
According to the Indianapolis Business Journal, the drug generated $577 million in sales for Lilly last year.The case is Eli Lilly & Co. v. [read post]
31 Jul 2011, 9:28 pm
"An assortment of medical organizations, researchers, genetic counselors, and patients" filed a declaratory judgment action against 15 claims of seven Myriad patents. [read post]
27 Jul 2011, 1:01 am by Marie Louise
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog)   Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
25 Jul 2011, 1:07 am by Melina Padron
will be decided this week, this time by the European Patent Office in Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33. [read post]
24 Jul 2011, 9:44 am by Blog Editorial
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 20 July 2011. [read post]
21 Jul 2011, 1:17 pm
The drug is being developed by Bristol-Myers Squibb and AstraZeneca, and other major manufacturers such as Johnson & Johnson and Eli Lilly are pursing similar drugs. [read post]
20 Jul 2011, 4:04 am by Marie Louise
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole)… [read post]
19 Jul 2011, 6:03 am by Mark Zamora
Here's the list for 2011 so far:  Potential Signals of Serious Risks/New Safety Information Identified by AERS, January to March 2011 Product Potential Signal of a Serious Risk/New Safety Information Additional Information (as of May 31, 2011) … [read post]
19 Jul 2011, 5:58 am by Mark Zamora
Eli Lilly & Co. said patients with Alzheimer’s disease whose conditions worsened upon taking the experimental drug semagacestat didn’t improve after dosing was halted. [read post]
19 Jul 2011, 4:39 am
The United Kingdom's Supreme Court is currently hearing the appeal in an important patent case, Human Genome Sciences Inc v Eli Lilly and Company UKSC 2010/0047. [read post]